Cite

HARVARD Citation

    Erkan, D. et al. (n.d.). A pilot open‐label phase II trial of rituximab for non‐criteria manifestations of antiphospholipid syndrome. Arthritis and rheumatism. 65 (2), pp. 464-471. [Online]. 
  
Back to record